Prevalence of major transfusion-transmissible viral infections in blood donors attending Fars Blood Transfusion Center, Shiraz, southern Iran: 2002-05

Iranian Journal of Medical Sciences

Volumn 32, Issue 2, 2007, Pages 114-117

  Kasraian, Leila ^a   Torab Jahromi, S A ^a  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Blood donor; Blood transfusion; Hepatitis B virus; Hepatitis C virus; Human immunodeficiency virus

Indexed keywords

HEPATITIS B SURFACE ANTIGEN;

ADULT; ARTICLE; BLOOD DONOR; BLOOD TRANSFUSION; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; IRAN; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PREVALENCE; STATISTICAL SIGNIFICANCE; VIRUS INFECTION; VIRUS TRANSMISSION; WESTERN BLOTTING;

EID: 39449136185     PISSN: 02530716     EISSN: 17353688     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Ankra-Badu GA, Ahmad M, Sowayan S, Bashawri L. Demographic characteristics of seropositive donors in Al-Khobar. Ann Saudi Med 2001; 21: 113-6.
2. Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ. The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study. N Engl J Med 1996; 334: 1685-90.
3. Lackritz EM, Satten GA, Aberle-Grasse J, et al. Estimated risk of transmission of the human immunodeficiency virus by screened blood in the United States. N Engl J Med 1995, 333: 1721-5.
4. Kleinman S, Busch MP, Korelitz JJ, Schreiber GB. The incidence/window period model and its use to assess the risk of transfusion-transmitted human immunodeficiency virus and hepatitis C virus infection. Transfus Med Rev 1997; 11: 155-72.
5. Kleinman S. Blood donor screening: Principles and policies In: Petz LD, Swisher SN, Kleinman S, Spence RK, Strauss RG, eds. Clinical Practice of Transfusion Medicine. 3rd ed. New York, NY: Churchill living stone Inc; 1996. p. 245-70.
6. Zuck TF. Transfusion-transmitted AIDS reassessed. N Engl J Med 1988; 318: 511-2.
7. Al Marzouqi M, Al Mahri A, Al Amiri A, et al. Achieving Zero risk in blood supply. Medlab Magazine 2005; Autumn: 29-32.
8. Kleinman S, Williams AE. Donor selection procedures: is it possible to improve them? Transfus Med Rev 1998; 12: 288-302.
9. Myhre BA, Figueroa PI. Infectious disease markers in various groups of donors. Ann Clin Lab Sci 1995; 25: 39-43.
10. Watanabe KK, Williams AE, Schreiber GB, Ownby HE. Infectious disease markers in young blood donors. Retrovirus Epidemiology Donor Study. Transfusion 2000; 40: 954-60.
11. Tanaka J, Moriya T, Sasaki F, et al. Prevalence of anti C100-3 and HBsAg in blood donors-comparative study of total collected blood units, total collection adjusted to exclude repeateded blood donations, and in first time blood donors. Nippon Koshu Eisei Zasshi 1993; 40: 540-6.
12. Williams AE, Thomson RA, Schreiber GB, et al. Estimates of infectious disease risk factors in US blood donors. Retrovirus Epidemiology Donor Study. JAMA 1997; 277: 967-72.